0.1 M EDTA (pH 8), and DNA was extracted as previously described (5) . PCR amplification with Taq DNA polymerase was done under standard conditions and with primers TRD5 (GATACTTGGTTGATCCTGCCAAGG) and TRD3 (GAT CCAACGGCAGGTTCACCTACC) (13) , which amplify only trichomonad small-subunit rRNA genes. Amplification was achieved by 30 cycles of 94°C for 1 min, 55°C for 1.5 min, and 72°C for 2 min. The 1.7-kbp PCR products were digested with 10 restriction enzymes, and the fragments were separated in 2.4% agarose gels (NuSieve 3:1 Agarose: FMC BioProducts) with appropriate size markers.
All nine stool samples positive for D. fragilis gave rise to short-term cultures of the ameba. Only 1 of 10 samples in which binucleate trophozoites were seen with Leishman stain did not contain D. fragilis in the iron-hematoxylin-stained preparation (it contained Endolimax nana). All of the D. fragilispositive patients had diarrhea, and five of nine patients reported abdominal pain. Seven had other parasites (five had B. hominis, one had Entamoeba coli, and one had Endolimax nana), and one was coinfected with Campylobacter spp. Infection with D. fragilis in our population appears to be short-lived. Five of the nine infected patients provided follow-up stool samples approximately 2 weeks after initial detection. None of the samples were positive in saline wet mounts or by culture, although one was found to be positive after iron-hematoxylin staining. The presence of D. fragilis was reported to the physician, but only the patient with the concurrent Campylobacter infection was treated, with ciprofloxacin.
Small-subunit rRNA genes were amplified successfully from D. fragilis in all cases. Two control samples were used: D. fragilis strain Bi/PA (ATCC 30948), for which the small-subunit rRNA gene sequence is available (13) , and a short-term D. fragilis culture from the London School of Hygiene and Tropical Medicine. Restriction patterns were identical for all isolates with eight enzymes (Sau3AI, Sau96I, HaeIII, HhaI, AluI, MspI, HinfI, and TaqI), but two enzyme patterns (RsaI and DdeI) were distinct in two isolates, one of which was Bi/PA. The patterns of the latter were exactly those predicted from the gene sequence. The two groups within the 12 isolates examined differed by only three restriction enzyme sites in their smallsubunit rRNA genes, a finding which extrapolates to approximately 2% sequence divergence.
The number of isolates examined was small; however, the less common of the two variants is present in both Europe and North America since Bi/PA (isolated in Illinois in 1948) shares the same pattern as one of our isolates (Fig. 1, lane 8) . The latter came from a 2-year-old child with no history of travel. We cannot exclude the existence of more variants within the species at present, as many more samples of geographically diverse origins are needed.
The existence of genetic variants in D. fragilis does not necessarily indicate that they have distinct effects in the human host, but it does show that organisms currently being reported as D. fragilis represent at least two significantly different genetic entities. The degree of divergence between them is comparable to that between Entamoeba histolytica and Entamoeba dispar, and it could be argued that they represent distinct species. We believe such a conclusion is premature, but our data do indicate that future studies of the role of D. fragilis in human disease need to take into account the existence of genetic diversity.
(This study formed part of an M.Sc. Thesis at the University of Surrey [J.A.J.])
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